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DNA microarrayTF genomic markers associatedwith neurogenesis, proliferation, differentiation, and epigenetic control in human
embryonic neural stem cells (hENSC(, and adult human olfactory bulb neural stem cells (OBNSC)were studied by
immunohistochemistry (IHC) and DNAmicroarray. The biological impact of TF gene changes in the examined cell
types was estimated using DAVID to specify a different GO class and signaling pathway based on KEGG database.
Eleven, and twenty eight TF genes were up-regulated (fold change≤2–39) in OBNSC, and hENSC respectively.
KEGG pathway analysis for the up-regulated TF genes revealed signiﬁcant enrichments for the basal transcription
factor pathway, and Notch signaling pathway in OBNSCs, and hENSCs, respectively. Immunoﬂuorescence analysis
revealed a signiﬁcantly greater number ofβ-tubulin III (TUBB3),MAP, glial ﬁbrillary acidic protein (GFAP), andO4
in hENSC when compared to those in OBNSC. Furthermore, the expression of epigenetic-related TF-genes
SMARCC1, TAF12, and UHRF1 increased signiﬁcantly in OBNSC when compared with hENSC.
© 2012 Elsevier Inc. All rights reserved.1. Introduction
Neural stem cells (NSC) are multipotent, self-renewal cells isolat-
ed from adult human olfactory bulb (OB) [1], and fetal brain tissue
[2]. They could also be obtained by differentiation of human embry-
onic stem cells (hENSC) using sets of well-deﬁned protocols [3]. Iso-
lation of NSCs from adult human OB represents an accessible source
of neural precursors [4], and is expected to provide an attractive tool
for transplantation-based therapy of neurodegenerative diseases
that avoids the ethical issues raised by the use of human embryos [5].
An increasing amount of information about the possible roles of tran-
scription factors (TFs) in regulation of various biological processes of
NSCs [6], is making it possible to utilize TF gene expression proﬁle to
explore variations in proliferation and differentiation potentiality of NSCs.
Several TFs had been implicated in NSC lineage speciﬁcation. In this
respect, Myt1 is found to be expressed in proliferating neural progeni-
tors, oligodendrocyte progenitor cells, and differentiating neurons [7].
Pax6 and Ascl1 regulate cohorts of genes that promote self-renewal,
basal progenitor cell genesis and neurogenesis [8]. Ascl1, POU3F2, and
Myt1L directly reprogram ﬁbroblasts into induced dopaminergic tyro-
sine hydroxylase (TH) positive neurons [9]. At the translational level,
direct reprogramming of somatic cells and NSCs with predeﬁned sets
of TF genes provides a fundamentally new approach for the generation
of patient-speciﬁc cells for in vitro diseasemodeling or direct therapeutic
applications [10], and highlights the signiﬁcance of TF gene regulation in
determining cell fate.of interest.
.
rights reserved.In our previous studies, we highlighted the global gene expression
proﬁle of adult human OBNSC, human embryonic NSC, and substantia
nigra cells which are known to be rich in dopaminergic neurons
[11,12]. In most cases, variation in global gene expression between
different cell lineages is reﬂected in the expression proﬁle of their
TFs. This strategy might lead us to restrict the global gene expression
proﬁle of these cells from whole human genome (DNA chip content)
to a fewer number of decisive TF genes.
Although there is a great interest and potential of adult and embry-
onic NSC's in cell replacement therapy, there is lack of data about their
TF gene expression proﬁling, andmolecular pathways that govern their
proliferation, and differentiation potential.Moreover, revealing possible
exposure of adult and embryonic NSC to epigenetic changes is crucial to
explore their future therapeutic potentials. A better understanding of
the molecular basis of the aforementioned processes would facilitate
choice of the best cell source for different neurodegenerative and trau-
matic CNS insults.
To this end, this study was designed to highlight possible varia-
tions in proliferation and differentiation potentials of adult human
OBNSC and hENSC as well as their possible exposure to epigenetic
marks by examining their TF gene expression and immunohisto-
chemical proﬁles.2. Materials and methods
2.1. Ethical issue
For the human embryonic NSC, ﬁve different (not replicate) cell
samples were purchased from Invitrogen derived from NIH-approved
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written consents for carrying out the operationswere obtained from the
patients undergoing brain surgery. Verbal consents for the probability
of isolating NSC from the collected OB tissue were also obtained from
the patients. Written and verbal consent were approved by the Ethical
Committee, Catholic University, School of Medicine, Rome, Italy, and
Ethical Committee of Mansoura University, Egypt.
2.2. Culturing of human embryonic NSCs
Cryopreserved human embryonic neural stem cells were plated in
a 6-well culture plate coated with polyethyleneimine, and incubated
at 37 °C in a 5% CO2/95% air incubator in serum-free DMEM/F12
medium (Invitrogen, Carlsbad, CA, USA) supplemented with a mix-
ture of insulin–transferrin–selenium (ITS) (Invitrogen, Carlsbad, CA,
USA), 20 ng/ml recombinant human EGF (Invitrogen, Carlsband, CA),
20 ng/ml recombinant human bFGF (Invitrogen, Carlsband, CA), and
10 ng/ml recombinant human LIF (Invitrogen, Carlsband, CA), according
to the methods described previously [13]. The half of the medium was
renewed every 4 days. Following incubation for several months, the
embryonic NSC in culture continued to proliferate by forming free
ﬂoating or loosely attached growing spheres. For microarray analy-
sis, nonpassage embryonic NSC spheres were harvested, replated in
a noncoated 6-well culture plate, and incubated further for 72 h in
the NSC medium without inclusion of 10% fetal bovine serum (FBS)
(Invitrogen, Carlsbad, CA, USA).
2.3. Isolation and culturing of human olfactory bulb NSCs
Immediately after removal, the OBs were dissociated in Papain
0.1% (Sigma-Aldrich, St. Louis, MO) for 30 min at 37 °C. Dissociated
cells were cultured in the presence of human recombinant EGF
(20 ng/ml; PeproTech, Rocky Hill, NJ), human recombinant bFGF
(10 ng/ml; PeproTech), and LIF (20 ng/ml; Immunological Sciences,
Rome, Italy) in DMEM/F12 (1:1) serum-free medium (Invitrogen,
Carlsband, CA) containing L glutamine 2 mM, glucose 0.6%, putrescine
9.6 μg/ml, progesterone 0.025 mg/ml, sodium selenite 5.2 ng/ml,
insulin 0.025 mg/ml, apo-transferrin sodium salt 0.1 mg/ml, sodium
bicarbonate 3 mM, Hepes 5 mM, BSA 4 mg/ml, and heparin 4 μg/ml.
Primary neurospheres were dissociated with Accutase (Invitrogen)
for 4 min at 37 °C, serially diluted and plated one cell per mini-well
onto 96-well plates. Mini-wells containing one single cell were
marked after microscopic conﬁrmation and assessed for secondary
neurosphere generation after one week. Secondary neurospheres
were subsequently dissociated, plated at the density of 103 cells/cm2
in serum-free medium containing EGF and bFGF, and passaged up to
P30. Between P7 and P10, parallel cultures were established in which
cells were grown as adherent monolayers in medium containing EGF
and bFGF supplemented with 5% fetal calf serum (Hyclone, Logan,
UT). Cells were counted with hemacytometer every 48 h. Differentia-
tion assays (the same for hENSC)were performed by 14 days after plat-
ing on Matrigel coated glass coverslips in the absence of EGF and bFGF
and in the presence of 1% fetal calf serum (Hyclone) supplemented
with 3′–5′-cyclic adenosine monophosphate (cAMP) 50 mM, all-trans
retinoic acid 5 mM (Sigma Aldrich), and triiodothyronine (T3) 30 nM
(Sigma Aldrich) [14].
2.4. Illumina bead chip hybridizations and analysis of expression data
Total cellular RNA was isolated from proliferating human embryonic
NSC (n=5, passage 2, different samples not replicates), and adult
human OBNSCs (n=5, passage 6, different samples not replicates)
using the Trizol (Invitrogen). Biotin labeled cRNAs were generated
from total RNA using a linear ampliﬁcation kit (Ambion, Austin, TX,
United States), and their concentrations were conﬁrmed with Nanodrop
ND-1000. The quality control step was performed using a BioRadExperion electrophoresis station. Illumina SentrixH HumanHT-12 v3
Expression Bead Chips were used. About 800 ng cRNA samples were
hybridized onto the speciﬁed chips at 58 °C overnight (19 h), scanned,
and the numerical results were extracted with GenomeStudio using
the Gene Expression Module v.1.0.6. Raw data were normalized using
the quantile normalization method (lumi software package) [15].
Normalized data were ﬁltered for genes with signiﬁcant expression
levels compared to negative control beads. Selection for differentially
expressed genes was performed on the basis of arbitrary thresholds for
fold changes plus statistical signiﬁcance according to the Illumina t-test
errormodel (limma software) [16]. ThemRNAarray data isMIAME com-
pliant and has been submitted to the NCBI Gene Expression Omnibus
(GEO) database (accession: under processing).2.5. Data analysis
2.5.1. TF genes differential expression analysis
We identiﬁed Gene Ontology (GO) groups of genes whose expres-
sion was differentially regulated among the classes. The evaluation of
which Gene Ontology classes are differentially expressed between
different classes was performed using a functional class scoring anal-
ysis as described by Pavlidis et al. [16]. For each gene in a GO class, the
p value for comparing classes was computed. The set of p values for a
class was summarized by two summary statistics: (i) the LS summary
is the average log p values for the genes in that class and (ii) the KS
summary is the Kolmogorov–Smirnov statistic computed on the p
values for the genes in that class. The statistical signiﬁcance of the
GO class containing n genes represented on the array was evaluated
by computing the empirical distribution of these summary statistics
in random samples of n genes. Functional class scoring is a more pow-
erful method of identifying differentially expressed gene classes than
the more common over-representation analysis or annotation of gene
lists based on individually analyzed genes. The functional class scor-
ing analysis for Gene Ontology classes was performed using BRB-
ArrayTools. Enrichment was determined in reference to all human
Entrez GeneIDs that were annotated in the Biological Process branch
(14,394 genes total). P-values were derived from a hypergeometric
test followed by the Benjamini and Hochberg false discovery rate
[17]. A P-value cutoff of 0.01 was used to identify signiﬁcantly
enriched categories.2.5.2. Functional annotation and molecular network analysis
Functional annotation of signiﬁcant genes identiﬁed by microarray
analysis was searched by the web-accessible program named Database
for Annotation, Visualization and Integrated Discovery (DAVID) version
2009, National Institute of Allergy and Infectious Diseases (NIAID),
National Institutes of Health (NIH) (david.abcc.ncifcrf.gov) [18].
DAVID covers more than 40 annotation categories, including Gene
Ontology (GO) terms, protein–protein interactions, protein functional
domains, disease associations, biological pathways, sequence general
features, homologies, gene functional summaries, and tissue expres-
sions. By importing the list of the National Center for Biotechnology
Information (NCBI) Entrez Gene IDs, this programcreates the functional
annotation chart, an annotation-term-focused view that lists annota-
tion terms and their associated genes under study. To avoid excessive
count of duplicated genes, the Fisher's exact test is calculated based
on corresponding DAVID gene IDs bywhich all redundancies in original
IDs are removed. Gene Ontology (GO) and KEGG molecular pathway
analysis was performed to identify possible enrichment of genes with
speciﬁc biological themes using both the data set as a whole and then
in the individual K-means clusters. DAVID calculates a modiﬁed Fishers
Exact p-value to demonstrate GO or molecular pathway enrichment,
where p-values less than 0.05 after Benjamini multiple test correction
are considered to be strongly enriched in the annotation category.
Fig. 1. Fluorescence image (20×) of GIBCOR hNSCs at passage 3 that has been cultured
in StemProR NSC SFM and stained for the NSC phenotype marker nestin (NES) (green)
and the proliferation marker Ki67 (red, A). Cell nuclei were counterstained with DAPI
(blue, A). Approximately 90% of the cells stain positive for the undifferentiated NSC
marker nestin (NES) and the proliferation marker Ki67. Lack of Oct4 staining indicates
that there are no remnant hESCs in the culture (data not shown) (Invitrogen, manual
part no. A11592, MAN0001758). Fluorescence images (20×) of GIBCOR hNSCs that
have been cultured in StemProR NSC SFM for three passages, and then allowed to
differentiate into neurons, oligodendrocytes, or astrocytes. Upon directed differentia-
tion, cells start to lose the undifferentiated NSC marker, nestin (NES), but stain positive
for the differentiated cell type markers Dcx, GalC, and GFAP. Cells were stained for the
undifferentiated NSC markers nestin (NES) (red, B) and SOX2 (green, C) prior to di-
rected differentiation. Cells were then differentiated into neurons and glial cells, and re-
spectively stained for the neuronal marker Dcx (green, C), for the oligodendrocyte
marker GalC (red, D), or for the astrocyte marker, GFAP (green, E). The nuclei were
counterstained with DAPI (blue) in panels B–D (Invitrogen, manual part no.
A11592, MAN0001758).
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The list of genes with predicted TF-binding sites in their regulatory
regions in each of our examined cell class were imported to g:Proﬁler.
The purpose of g:Proﬁler is to ﬁnd common high-level knowledge
such as pathways, biological processes, molecular functions, subcellu-
lar localizations, or shared TF binding sites (TFBS) to the list of input
genes. The data used in g:Proﬁler is derived from the Gene Ontology
[19], KEGG [20], Reactome [21] and TRANSFAC [22] databases.
2.5.4. Immunohistochemical validation of selected genes
For immunocytochemistry, proliferating (P2 hENSC, P6 OBNSCs)
and differentiating (P3 ENSC, and P9 OBNSC) attached on poly-L-
lysine-coated cover glasses were ﬁxed with 4% PFA in 0.1 M phos-
phate buffer, pH 7.4 at room temperature (RT) for 5 min, followed
by incubation with phosphate-buffered saline (PBS) containing 0.5%
Triton X-100 at RT for 3 min. After blocking non-speciﬁc staining by
PBS containing 10%NGS, the cellswere incubated in primary antibodies.
We used antibodies against nestin (NES) (Chemicon, Temecula, CA),
GFAP (Dako, Glostrup, Denmark), β-tubulin III (TUBB3) (Chemicon),
neuroﬁlament RT-97 (Developmental Studies Hybridoma Bank, Iowa
City, IA), MAP2 (Chemicon), NG2 (Chemicon), and O4 (Chemicon).
Then, they were incubated at RT for 30 min with a mixture of
FITIC-conjugated anti-rabbit IgG (Invitrogen) and TRITIC-conjugated
anti-mouse IgG (Invitrogen). After several washes, theywere examined
on the Olympus BX51 universal microscope. Immunostaining of NS/PCs
was performed.
3. Result and discussion
3.1. Embryonic human NSCs in culture
Passage two Invitrogen hENSC derived from NIH-approved H9
(WA09) human embryonic stem cells (hESCs) were characterized
based on the manufacturer's instruction manual. A single cell suspen-
sion of hENSC was cultured in serum-free DMEM/F12 medium
supplemented with EGF and bFGF. The cells gave rise to proliferating
neurospheres, ﬁrst appearing within 72 h of primary culture and
increasing their numbers and diameters quickly during 7 days after
the onset of the culture. Approximately 90% of the cells stained posi-
tive for the undifferentiated NSC marker nestin (NES), SOX2 and the
proliferation marker Ki67 (Figs. 1A,B). The differentiation capacity of
hENSC in differentiating conditions was revealed by examining the
types of molecular markers expressed by neurons and glial cells in
passage 3 hENSC. These cells could differentiate into, Dcx-positive
immature neurons (25%) (Fig. 1C), GalC positive oligodendrocyte
(5%) (Fig. 1D), and GFAP positive astrocyte (70%) (Fig. 1E).
3.2. Adult human OBNSCs in culture
Passage 3 dissociated adult human OB specimens were cultured in
serum-free medium supplemented with the mitogens EGF and bFGF.
Under these conditions, the OB cells generated primary neurospheres
with latencies that ranged from 6 to 8 weeks. When passage 9 adult
human OBNSC spheres were split into single cells with Accutase and
incubated in the NSCmedium supplementedwith 10% FBS, they rapidly
attached on the plastic surface, and started to differentiate into the dif-
ferent neuronal and glial lineages. The proliferated human OBNSC
exhibited an intense immunoreactivity for GFAP astrocyte marker
(75%), MAP2 immature neuronal marker (17.5%), and β-tubulin
(TUBB3) mature neuronal marker (5%) (Figs. 2A,B). None of the cells
expressed the oligodendrocyte marker O4.
From the IHC results, hENSCs differentiated into astrocytes (70%),
oligodendrocytes (5%), and neurons (25%). The proliferation and dif-
ferentiation potentials of adult OBNSC were comparable to those of
the embryonic ones where they differentiated into astrocytes (75%),and neurons (17.5%), but not oligodendrocytes, demonstrating that
in comparison to hENSCs, OBNSCs had restricted neuronal and oligo-
dendrocyte differentiation in vitro, and therefore are expected to be
less effective in regard to neuronal and oligodendrocyte replacement
therapy. Previous studies demonstrated that adult NSCs are able to
differentiate into both glia and neurons, but only under particular
growth conditions including co-culturing with embryonic stem
cell-derived neural precursors [23]; this suggests that adult NSC
appear to lack key factors required for neuronal differentiation. The
restricted in vitro neuronal differentiation capacity of adult NSCs is
supported by other in vivo studies where it was demonstrated that
following engraftment, adult NSC differentiated into astrocytes and
oligodendrocytes, but not neurons [24].
Fig. 2. Differentiation potential of short-term proliferated human OBNS cells. Fluorescent phase contrast images of passage 9 human OBNS immunostained for the GFAP astrocyte
marker, MAP2 immature neuronal marker, and β-tubulin (TUBB3) mature neuronal marker. Scale bar, 100 μm. The nuclei were stained blue with DAPI. The plot shows the percent-
age of positive GFAP astrocytes, MAP2 immature, and β-tubulin (TUBB3) mature neurons, generated by each cell type.
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In order to highlight a possible variation in the proliferation
potential of our hENSC, and OBNSCs, we studied the gene expression
proﬁle of their TF genes during their proliferation phase, passage 3,
and 6 respectively. In passage 6 proliferating OBNSCs, eleven TF
genes were up-regulated (fold change≤6–30). The expression of
FOXO4, CTNNB1, NFIC, TGIF1, GTF2H4, TSHZ1, HNRNPAB, FOXN2,
ZFP36L2, HNRNPK, and TAF12 were up-regulated by 30.1, 25.98,
21.84, 19.98, 17.03, 16.31, 13.88, 11.85, 11.51, 11.41, and 6.38 fold
respectively (Fig. 3, Tables S1, S2).
3.4. GO clustering of up-regulated TF genes of OBNSC
GO clustering using DAVID for the 11 up-regulated TF genes (fold
change≤6.38–30.1) of OBNSCs revealed three main clusters (Table 1).
The ﬁrst annotation cluster with an enrichment score of 4 include:
transcription regulator activity (7 genes), regulation of RNA metabolic
process (7 genes), transcription factor activity (6 genes), regulation ofFig. 3. Up-regulated and down-regulated TF genes between hENSC and OBNSC. Eleven TF gene
GTF2H4, TSHZ1, HNRNPAB, FOXN2, ZFP36L2, HNRNPK, and TAF12 were up-regulated by 30.1,
hENSCs, 28 TF genes were up-regulated (fold change≤2.13–39.1) (Tables S1, S2). The expres
ATF6, MSRB2, ETV5, HOXB7, BATF3, KDM5B, HDAC1, HCFC1, TCF25, UHRF1, HNRNPAB, HES6,
3.49, 3.81, 4.33, 4.72, 5.41, 5.81, 6.41, 6.76, 6.94, 7.16, 8.64, 8.48, 9.48, 13.95, 14.98, 15, 16.80, 1transcription (7 genes), DNA binding (7 genes), regulation of transcrip-
tion (6 genes), DNA-dependent (6 genes), and nucleus (6 genes).
3.5. KEGG pathway analysis of TF up-regulated genes of OBNSC
KEGG pathway analysis of the eleven TF up-regulated genes (fold
change≤6.38–30.1) of OBNSCs showed a signiﬁcant enrichment for
basal transcription factor pathway.
3.6. TF gene expression proﬁle of hENSC
In hENSCs, 28 TF geneswere up-regulated (fold change≤2.13–39.1)
(Tables S1, S2). The expression of ZNF33B, TRIM25, HOXC8, YEATS4,
ZHX2, SUPT4H1, LHX2, HOPX, GAS7, RFXANK, ATF6, MSRB2, ETV5,
HOXB7, BATF3, KDM5B, HDAC1, HCFC1, TCF25, UHRF1, HNRNPAB,
HES6, HDAC2, DRAP1, EDF1, RCAN1, ATF4, and JUN were up-regulated
by 2.13, 2.56, 2.68, 3.28, 3.49, 3.81, 4.33, 4.72, 5.41, 5.81, 6.41, 6.76,
6.94, 7.16, 8.64, 8.48, 9.48, 13.95, 14.98, 15, 16.80, 19.29, 21.43, 22.03,
27.28, 29.26, 38.75, and 39.44 fold respectively.s were up-regulated (fold change≤6–30). The expression of FOXO4, CTNNB1, NFIC, TGIF1,
25.98, 21.84, 19.98, 17.03, 16.31, 13.88, 11.85, 11.51, 11.41, and 6.38 fold respectively. In
sion of ZNF33B, TRIM25, HOXC8, YEATS4, ZHX2, SUPT4H1, LHX2, HOPX, GAS7, RFXANK,
HDAC2, DRAP1, EDF1, RCAN1, ATF4, and JUN were up-regulated by 2.13, 2.56, 2.68, 3.28,
9.29, 21.43, 22.03, 27.28, 29.26, 38.75, 39.44 fold respectively.
Table 1
GO clustering using DAVID for the 11 up-regulated TF genes (fold change≤6.38–30.1)
of OBNSCs.
Annotation cluster 1 Enrichment score: 4 Count P value Benjamini
GOTERM_MF_FAT Transcription regulator activity 7 1.4E−
5
6.2E−4
GOTERM_BP_FAT Regulation of RNA metabolic
process
7 2.0E−
5
5.2E−3
GOTERM_MF_FAT Transcription factor activity 6 3.0E−
5
6.5E−4
GOTERM_BP_FAT Regulation of transcription 7 1.2E−
4
1.5E−2
GOTERM_MF_FAT DNA binding 7 1.2E−
4
1.8E−3
GOTERM_BP_FAT Regulation of transcription,
DNA-dependent
6 3.6E−
4
3.0E−2
SP_PIR_KEYWORDS Nucleus 6 2.3E−
3
5.9E−2
Annotation cluster 2 Enrichment score: 2.06 Count P value Benjamini
GOTERM_MF_FAT Transcription factor activity 6 3.0E−
5
6.5E−4
SP_PIR_KEYWORDS Nucleus 6 2.3E−
3
5.9E−2
GOTERM_MF_FAT Transcription activator activity 3 4.7E−
3
4.9E−2
SP_PIR_KEYWORDS Transcription regulation 4 5.0E−
3
6.3E−2
SP_PIR_KEYWORDS Transcription 4 7.6E−
3
4.9E−2
GOTERM_BP_FAT Positive regulation of
transcription
3 1.4E−
2
5.9E−1
GOTERM_BP_FAT Positive regulation of gene
expression
3 1.5E−
2
5.4E−1
GOTERM_BP_FAT Positive regulation of
nucleobase, nucleoside,
nucleotide and nucleic acid
metabolic process
3 1.7E−
2
5.2E−1
GOTERM_BP_FAT Positive regulation of nitrogen
compound metabolic process
3 1.8E−
2
4.8E−1
GOTERM_BP_FAT Positive regulation of
macromolecule biosynthetic
process
3 2.0E−
2
4.7E−1
GOTERM_BP_FAT Positive regulation of cellular
biosynthetic process
3 2.1E−
2
4.2E−1
GOTERM_BP_FAT Positive regulation of
biosynthetic process
3 2.2E−
2
4.0E−1
GOTERM_BP_FAT Positive regulation of
macromolecule metabolic
process
3 2.9E−
2
4.7E−1
GOTERM_BP_FAT Transcription 3 7.0E−
2
7.6E−1
Annotation cluster 3 Enrichment score: 1.61 Count P value Benjamini
GOTERM_CC_FAT Nucleoplasm 3 4.3E−
3
2.3E−1
GOTERM_CC_FAT Nuclear lumen 3 1.1E−
2
2.8E−1
GOTERM_CC_FAT Intracellular organelle lumen 3 2.0E−
2
3.3E−1
GOTERM_CC_FAT Organelle lumen 3 2.0E−
2
2.6E−1
GOTERM_CC_FAT Membrane-enclosed lumen 3 2.1E−
2
2.3E−1
SP_PIR_KEYWORDS Phosphoprotein 3 6.2E−
1
9.9E−1
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(fold change≤2.13–39.1) of hENSCs revealed the presence of two
groups: the ﬁrst group with an enrichment score of 10.22 contained
8 different TF functional groups, and the second group with an
enrichment score of 8.58 contained 12 different TF functional groups.
(Table 2).3.7. GO clustering of up-regulated TF genes of hENSCs
GO clustering using DAVID for the 28 up-regulated TF genes (fold
change≤2.13–39.1) of hENSCs revealed 11 clusters (Table 2). The ﬁrst
annotation cluster with an enrichment score of 25.33 include: transcrip-
tion factor activity (28 genes), transcription regulator activity (28 genes),
and DNA binding (28 genes). The second annotation cluster with an
enrichment score of 13.25 include: regulation of transcription, DNA-
dependent (22 genes), transcription regulation (21 genes), regulation
of RNA metabolic process (22 genes), transcription (21 genes), regula-
tion of transcription (24 genes), transcription (22 genes), and nucleus
(24 genes).
3.8. KEGG pathway analysis of TF up-regulated genes of hENSCs
KEGG pathway analysis of the 28 TF up-regulated genes (fold
change≤2.13–39.1) of hENSCs showed signiﬁcant enrichment for
pathways in cancer, Notch signaling pathway, and chronic myeloid
leukemia (Table 3).
3.9. TF genes relevant to proliferation
The differences in the neuronal and glial differentiation potential
between hENSC and OBNSC that had been revealed in the present
study could be explained based on their TF gene expression proﬁle.
In this respect, it had been demonstrated that ZHX2 was up-regulated
in hENSC as compared to OBNSC. Blocking ZHX2 function in cultured
neural progenitor cells or in the embryonic cortex causes neuronal
differentiation, whereas overexpression of ZHX2 disrupts the normal
differentiation of cortical neural progenitor cells [25]. The high
expression level of ZHX2 in our hENSC might explain the relatively
low neuronal differentiation potential (25% neurons) relevant to the
higher glial differentiation (75% astrocytes) potential.
The comparatively higher neuronal differentiation potential of
hENSCs in comparison to OBNSC that had been demonstrated in the
present work might be further explained by the observation that
HES6 was up-regulated in hENSCs relative to OBNSC where Hes6 is
known to play a role in primary neurogenesis. Depletion of Hes6 by
morpholino antisense oligonucleotides results in a failure of neural
differentiation [26].
MSRB2, KDM5B, and HDACs were up-regulated in our hENSC as
compared to OBNSc. The overexpression MSRB2 is known to pre-
serve themitochondrial integrity, and hence contribute to cell prolif-
eration, survival and protein maintenance [27]. KDM5B activates
self-renewal-associated gene expression [40]. HDACs negatively
control histone acetylation and occupies mainly active genes, includ-
ing important regulators of NSC self-renewal and proliferation [41].
FOXO4was found to be down-regulated in hENSCs as compared to
our adult OBNSC. Loss of FOXO function has been identiﬁed in several
human cancers, and results in increased cellular survival and a predis-
position to neoplasia, especially in epithelial cancer. FOXO factors are
therefore bona ﬁde tumor suppressors. The low constitutive expres-
sion level of FOXO4 in hENSCs in comparison to OBNSCmight indicate
their higher tumorigenic potential in comparison to OBNSCs. Among
other TFs related to proliferation activities of NSC, Foxn2 was found
to be up-regulated in our OBNSCs. In this respect Foxn2 had been
identiﬁed as key regulators of embryogenesis, cell cycling, cell lineage
restriction and cancer [28].
Another proliferation-related TF gene that was up-regulated in our
OBNSC is TGIF1which negatively affects TGFβ signaling, and is implicat-
ed in regulation of cell growth, apoptosis and differentiation. TGFβ has
been implicated in various human disorders ranging from vascular dis-
eases to cancer. Cancer cell lines with inactivating mutations in Fbxw7
showenhanced levels of TGIF1 and attenuated TGFβ-dependent regula-
tion of cell growth and migration [29]. The up-regulation of TGIF1 TF
genes in our OBNSCs might point to their enhanced growth,
Table 2
GO clustering using DAVID for the 28 up-regulated TF genes (fold change≤2.13–39.1)
of hENSCs.
Annotation cluster 1 Enrichment score: 25.33 Count P value Benjamini
GOTERM_MF_FAT Transcription factor activity 28 3.1E−
31
2.1E−29
GOTERM_MF_FAT Transcription regulator activity 28 5.0E−
26
1.7E−24
GOTERM_MF_FAT DNA binding 28 6.4E−
21
1.5E−19
Annotation cluster 2 Enrichment score: 13.25 Count P value Benjamini
GOTERM_BP_FAT Regulation of transcription,
DNA-dependent
22 9.0E−
15
3.4E−12
SP_PIR_KEYWORDS Transcription regulation 21 1.1E−
14
7.1E−13
GOTERM_BP_FAT Regulation of RNA metabolic
process
22 1.4E−
14
2.7E−12
SP_PIR_KEYWORDS Transcription 21 1.7E−
14
5.4E−13
GOTERM_BP_FAT Regulation of transcription 24 4.4E−
14
5.6E−12
GOTERM_BP_FAT Transcription 22 2.8E−
13
2.7E−11
SP_PIR_KEYWORDS Nucleus 24 6.4E−
12
1.4E−10
Annotation cluster 3 Enrichment score: 6.89 Count P value Benjamini
GOTERM_BP_FAT Regulation of transcription
from RNA polymerase II
promoter
13 2.6E−
9
1.9E−7
GOTERM_BP_FAT Negative regulation of
transcription, DNA-dependent
10 1.2E−
8
7.2E−7
GOTERM_BP_FAT Negative regulation of RNA
metabolic process
10 1.3E−
8
7.2E−7
SP_PIR_KEYWORDS Repressor 9 9.8E−
8
1.3E−6
GOTERM_BP_FAT Negative regulation of
transcription
10 1.0E−
7
4.8E−6
GOTERM_BP_FAT Negative regulation of gene
expression
10 2.3E−
7
9.5E−6
GOTERM_BP_FAT Negative regulation of
nucleobase, nucleoside,
nucleotide and nucleic acid
metabolic process
10 2.6E−
7
9.8E−6
GOTERM_BP_FAT Negative regulation of nitrogen
compound metabolic process
10 2.9E−
7
1.0E−5
GOTERM_BP_FAT Negative regulation of
macromolecule biosynthetic
process
10 4.6E−
7
1.4E−5
GOTERM_BP_FAT Negative regulation of
macromolecule metabolic
process
11 5.0E−
7
1.4E−5
GOTERM_BP_FAT Negative regulation of
transcription from RNA
polymerase II promoter
8 5.0E−
7
1.3E−5
GOTERM_BP_FAT Negative regulation of cellular
biosynthetic process
10 5.6E−
7
1.4E−5
GOTERM_BP_FAT Negative regulation of
biosynthetic process
10 6.7E−
7
1.6E−5
Table 3
KEGG pathway analysis of the 28 TF up-regulated genes (fold change≤2.13–39.1) of
hENSCs showed signiﬁcant enrichment for three pathways (pathways in cancer,
Notch signaling pathway, and chronic myeloid leukemia).
Category Term Count % P-value Benjamini
KEGG_PATHWAY Pathways in cancer 3 1.1 5.2E−2 7.1E−1
KEGG_PATHWAY Notch signaling pathway 2 0.7 5.4E−2 4.7E−1
KEGG_PATHWAY Chronic myeloid leukemia 2 0.7 8.5E−2 5.0E−1
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tional coactivator of p53 was up-regulated in both our OBNSCs and
hENSC. Phosphorylation of HNRNPK by Aurora-A (AURKA) disrupts its
interactionwith p53. Inverse correlation between Aurora-A (AURKA) ac-
tivity andHNRNPK–p53 interactionwas demonstrated in DNA-damaged
cells [30]. Among the 28 TF genes that were up-regulated (fold
change≤2.13–39.1) (Fig. 3, Tables S1, S2) in hENSCs, several TFs were
found to be related to the proliferation control. In this respect, in compar-
ison to our OBNSCs, TRIM25, andHoxc8were up-regulated in hENSC and
both are known to be involved in various cellular processes, including
cell proliferation activity [31]. Moreover, Hoxc8 reduces cell adhesionand concomitant cell migration [32].Whether or not the high expression
level of Hoxc8 identiﬁed in our hENSC could compromise theirmigration
and differentiation potential in comparison to OBNSC is amatter that still
needs more elucidation.
3.10. Tumorigenic potential of hENSC vs. OBNSC
Next, we had assessed the tumorigenic potential of hENSC and
OBNSC based on their TF gene expression proﬁle. Tumor suppression
TF genes such as CTNNB1were also up-regulated in OBNSC. Defects in
CTNNB1 are a cause of medulloblastoma [33]. CTNNB1 is a central
component of the Wnt/β-catenin signaling pathway which plays an
important role in adult neurogenesis [33]. The high expression proﬁle
of CTNNB1 in our OBNSCs might highlight the crucial role of OBNSCs
in the generation of new neurons during adult life.
HDAC2 is up-regulated in hENSCs, a ﬁnding that might indicate its
pronounced tumorigenic potential as compared to the adult OBNSCs.
Histone deacetylases (HDAC2) control cellular signaling and gene
expression. It is crucial for embryonic development, affects cytokine
signaling relevant for immune responses and is often signiﬁcantly
over-expressed in solid tumors [34]. ATF4 was up-regulated in our
hENSCs. ATF4 mutations is found in tumor cells and associated with
anticancer drug resistance [35]. Such ﬁnding might indicate the pos-
sible tumorigenic potential of our hENSC in comparison to the
OBNSCs.
Other tumorigenic TF genes such as YEATS, YEATS4, HOPX, ETV5
were also found to be up-regulated in hENSC as compared to OBNSC.
In this regard, YEATS domain family members, such as YEATS4,
MLLT1, and MLLT3, were found to have a strong link to cancer.
YEATS4 is ampliﬁed in glioblastomas and astrocytomas; MLLT1 and
MLLT3 are among the most frequent translocation partners of the
mixed lineage leukemia (MLL) gene [36]. The high expression level of
YEATS in our hENSC might highlight the possible tumorigenic potential
of these cells following engraftments as compared to OBNSCs. Tran-
scriptional silencing of HOPX results from hypermethylation of the
HOP promoter leads to cancer development [37]. ETV5 is central to
both tumor invasion and angiogenesis [38]. The up-regulation of ETV5
in our hENSC might highlight the possible tumorigenic potential of this
cell line. HOXB7 acts as a key regulator, orchestrating a major group of
target molecules in the oncogenic hierarchy. Higher expression levels of
HOXB7 in the tumor signiﬁcantly correlatedwith poorer disease-free sur-
vival in ERα-positive patients with breast cancer on adjuvant tamoxifen
monotherapy [39].
Relevant to the tumorigenic potential of human OBNSC, it has been
previously reported that the tumor-like growth properties of the stem
cells associate with changes either in oncosuppressors or in oncogenes
[40]. Tumorigenic olfactory bulb NS/PCs showed up-regulation of genes
related to cell proliferation and inhibiting apoptosis, though solely
hTERT and NOTCH1 were overexpressed independently from mitogen
stimulation. Tumorigenic OBNSCs did express the hTERT protein,
which was undetectable in non-tumorigenic NS/PCs, consistent with
that reported in normal NS cells [27]. Immunoﬂuorescence with
anti-NOTCH1 antibody on tumorigenic OBNSCs demonstrated either
increased cytoplasmic staining or abnormal nuclear staining. Following
NOTCH1 blockade with the γ-secretase inhibitor X (GSI), OBNSCs lost
their ability to form soft-agar colonies suggesting a functional role of
18 H.E.S. Marei, A.-E. Ahmed / Genomics 101 (2013) 12–19NOTCH1 in the tumorigenicity of these cells. Although the xenografts
grown after injection of OB3a and SS-OB2a NS/PCs were histologically
reminiscent of different tumors, in both of them molecular analyses
pointed to hTERT and NOTCH1 as critical pathways. Telomerase is
highly expressed in the majority of human cancers including
glioblastoma, where it is believed to contribute to tumor progression
because telomerase-dependent telomeremaintenance provides cells
with an extended proliferative potential [27]. NOTCH is known to
promote the proliferation of nonneoplastic NSCs and to inhibit
their differentiation; it is also highly activated in embryonal brain
tumors, such as medulloblastoma, where it is required both for
maintaining the stem cell fraction in vitro and for tumor formation
in vivo [41]. Up-regulation of hTERT and NOTCH1 in tumorigenic
OBNSCS suggests that a common mechanism may underlay the
malignant transformation of these cells [27].
3.11. Epigenetic control
Differences in the proliferation and differentiation potentials
between the embryonic and adult NSC during in vitro condition
might be explained based on variation in the genomic and epigenetic
proﬁles of the two cell populations. In this regard, Marei et al. [11,12]
used the transcriptional signature of hENSC and adult human OBNSCs
to decipher genes involved in epigenetic modiﬁcations such as
SMARCC1, SMARCE1, and DNMT3B which were found speciﬁcally
up-regulated in our OBNSC but not in hENSC and may interact with
proteins encoded by other speciﬁc genes such as ARID2 and ARID1B
[42]. Another TF that is relevant to epigenetic control of NSC is
TAF12 which was up-regulated in OBNSCs in comparison to our
hENSCs. The TAF12 is a TBP-associated factor that is contained in
Pol I- and Pol II-speciﬁc TBP–TAF complexes, and it plays a crucial
role in demethylation of rDNA [43].
4. Conclusion
Changes in expression of the cytoplasmic markers and transcrip-
tion factor genes associated with neurogenesis, proliferation and dif-
ferentiation in human embryonic neural stem cells (hENSCs), and
adult human olfactory bulb neural stem cells (OBNSCs) were exam-
ined by immunohistochemistry and DNA microarray. Eleven, and
28, TF genes were up-regulated in OBNSCs, and hENSC, respectively.
GO clustering and KEGG pathway analysis revealed a signiﬁcant
enrichment for the basal transcription factor pathway, and Notch sig-
naling pathway in OBNSC, and hENSC respectively.
Immunoﬂuorescence analysis of the differentiated hENSC andOBNSC
revealed a signiﬁcantly greater number of β-tubulin III (TUBB3), MAP,
glial ﬁbrillary acidic protein (GFAP), and O4 in hENSC when compared
to those in OBNSC. Furthermore, the expression of epigenetic-related
TF-genes SMARCC1, TAF12, and UHRF1 increased signiﬁcantly in
OBNSC when compared with hENSC. Taken together, the present study
reveals distinct proliferation, differentiation and epigenetic control be-
tween hENSC and OBNSC. Such ﬁnding is expected to generate new ad-
vances for selecting the best cell source for future treatments for different
traumatic and neurodegenerative CNS injuries.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ygeno.2012.09.006.
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